C
BIIB icon

CFO4Life’s Biogen BIIB Stock Holding History

CFO4Life’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$359K Sell
1,266
-72
-5% -$21.3K 0.3% 59
2016
Q3 		$419K Sell
1,338
-85
-6% -$25.2K 0.36% 48
2016
Q2 		$344K Buy
1,423
+197
+16% +$51.9K 0.29% 62
2016
Q1 		$319K Buy
+1,226
New +$324K 0.29% 66

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CFO4Life's BIIB Position: Q4 2016 in Review

CFO4Life reduced its Biogen (BIIB) stake by 5.4% in Q4 2016, selling an estimated $21.3K and leaving 1,266 shares worth $359K. The position accounts for 0.3% of the portfolio, ranked #59.

CFO4Life first reported a position in BIIB in Q1 2016 and has held it in 4 quarters since. The position peaked at $419K in Q3 2016. 1,025 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

  • CFO4Life held 1,266 shares of Biogen worth $359K as of Q4 2016.
  • CFO4Life sold 72 Biogen shares in Q4 2016, an estimated $21.3K.
  • Biogen made up 0.3% of CFO4Life's portfolio in Q4 2016, its #59 holding.
  • CFO4Life first reported a position in Biogen in Q1 2016 and has held it in 4 quarters since.
  • CFO4Life's Biogen position peaked at $419K in Q3 2016.
  • 1,025 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on CFO4Life's 13F filing for Q4 2016, filed 30 Jan 2017.